Featured Clinical Leader Editorial
-
A Closer Look At Precision Medicine Clinical Trials
1/9/2024
As Sumitomo Pharma America (SMPA) starts to focus more on precision medicine, the sponsor is encountering a new set of challenges when it comes to running clinical trials.
-
Which Therapeutic Areas Experts Think Will Gain Traction In 2024
1/2/2024
In part four, experts discuss several therapeutic areas and their advancements they believe deserve and will garner interest in 2024.
-
The Current State Of Sustainability In Clinical Trials
12/19/2023
From exploring decentralized trial elements to making operations carbon-negative, the clinical research industry is aligning its goals with broader global sustainability initiatives.
-
How Re-educating PIs Can Improve Clinical Trial Diversity
12/14/2023
Usually, discussions around ways to improve diversity in clinical trials focus on changing traditional protocol-design processes, finding and tapping into larger pools of diverse patients, educating patients on the value of clinical trials — that type of stuff. You don't normally hear people talking about re-educating physicians as a solution.
-
New Calculator Could Help Trial Participants And Sponsors Determine Costs And Fair Compensation
12/14/2023
Try the industry’s first open access financial burden calculator to help patients, sponsors, and other stakeholders estimate the cost burden patients may face.
-
Trip Or No Trip: Pharmas Are Taking Psychedelic Trials To Australia
12/13/2023
Enveric Biosciences CEO Joseph Tucker, Ph.D., chronicles the company's quest for regulatory approval in Australia, as well as navigates the unknowns of developing psychedelics for therapeutic use.
-
Who Are Your TMF Customers? The Key To Greater Trial Efficiency & Quality
12/12/2023
Could your director of clinical operations or TMF manager identify all customers of the TMF? Perhaps not. Learn why knowing all customers is so important to efficient, high-quality trials.
-
A Primer For Understanding Psychedelic Clinical Research
12/11/2023
The emerging field of clinical research on psychedelics brings a unique and transformative approach to CNS drug development. Explore more.
-
Can Data Help Improve Diversity In Clinical Trials?
12/7/2023
Denise Bronner Ph.D., director of diversity, equity, and inclusion in clinical trials at Johnson & Johnson Innovative Medicine (JJIM) talks about some of the types of datasets that can be leveraged to improve diversity in clinical trials.
-
Identifying Digital Endpoints For Fatigue To Drive Better Clinical Care And Treatments
11/28/2023
The absence of clear biological indicators for fatigue makes diagnosing and finding effective treatments difficult. Cambridge Cognition's Michele Veldsman, Ph.D. is working to develop better biomarkers to improve diagnosis, care, and treatment.